| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 704 |
| 1 | LAMIVUDINE ORAL | 704 |
| 2 | EFAVIRENZ | 381 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE | 339 |
| 4 | TACROLIMUS | 332 |
| 5 | PREDNISONE | 329 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 326 |
| 7 | TACROLIMUS OINTMENT 0.1% | 326 |
| 8 | FLUCONAZOLE | 317 |
| 9 | PREDNISOLONE | 295 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRINCIDOFOVIR | 11 | 0.0791 |
| 1 | FLUCYTOSINE | 105 | 0.0740 |
| 2 | MEFLOQUINE HYDROCHLORIDE | 8 | 0.0513 |
| 3 | HYDROCORTISONE OINTMENT | 1 | 0.0500 |
| 4 | RIFABUTIN | 119 | 0.0432 |
| 5 | EFAVIRENZ | 381 | 0.0343 |
| 6 | EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0333 |
| 7 | DARUNAVIR 600 MG | 175 | 0.0283 |
| 8 | PYRAZINAMIDE | 265 | 0.0280 |
| 9 | LAMIVUDINE | 704 | 0.0279 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 105 | 0.0740 |
| 1 | Rifamycin Antimycobacterial [EPC] | 119 | 0.0340 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 519 | 0.0216 |
| 3 | CD4-directed Blocking Antibody [EPC] | 11 | 0.0204 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 791 | 0.0161 |
| 5 | Antimycobacterial [EPC] | 340 | 0.0139 |
| 6 | CCR5 Co-receptor Antagonist [EPC] | 30 | 0.0131 |
| 7 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 16 | 0.0126 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1387 | 0.0126 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 161 | 0.0125 |